Motif Neurotech has won a funding grant from the UK government’s Advanced Research and Invention Agency (ARIA) to advance its therapeutic brain-computer interface (BCI) technology for treating cognitive and psychiatric conditions.
Intended to help regulate brain states associated with mood, attention, and sleep, Motif’s BCI tech is comprised of a network of millimetre-sized wireless implants that are placed in a patient’s skull during a 20-minute procedure. According to the company, without contacting the brain, each device provides cell-type specific stimulation and electrical recording to regulate brain-wide circuits in a way that meets the needs of each individual patient.
Described as in the “multimillion dollar” range, Motif will use the funds to develop the device in collaboration with research…